BioHealth News Archive

The 50 Most Influential People in Health Care of 2018 – Time.com

The 50 Most Influential People in Health Care of 2018 – Time.com

Meet the physicians, scientists, and business and political leaders whose work is transforming health care right now {iframe}http://time.com/collection/health-care-50/?utm_source=time.com&utm_medium=email&utm_campaign=the-brief&utm_content=2018101910am&xid=newsletter-brief&eminfo=%7b%22EMAIL%22%3a%22FQSen6Gi%2bvP1kwg88K1Rt6yTrkkPMrpS%22%2c%22BRAND%22%3a%22TD%22%2c%22CONTENT%22%3a%22Newsletter%22%2c%22UID%22%3a%22TD_TBR_187335EB-AD8D-40AA-AE90-07F18992A3F1%22%2c%22SUBID%22%3a%2223900093%22%2c%22JOBID%22%3a%22906583%22%2c%22NEWSLETTER%22%3a%22THE_BRIEF%22%2c%22ZIP%22%3a%22%22%2c%22COUNTRY%22%3a%22USA%22%7d{/iframe}

Read More
3 ways HHS can help medtech innovators – Medical Design and Outsourcing

3 ways HHS can help medtech innovators – Medical Design and Outsourcing

The U.S. Department of Health and Human Services (HHS) is doing everything from sharing more data to cultivating entrepreneurial talent and engaging in partnerships…

Read More
VLP Therapeutics Announces Issuance of US Patent for Dengue Vaccine – VLP Therapeutics

VLP Therapeutics Announces Issuance of US Patent for Dengue Vaccine – VLP Therapeutics

VLP Therapeutics announced the issuance of US Patent 10,098,943 titled, “Flavivirus virus-like particle” on October 16, 2018. This patent supports VLP Therapeutics’ Native Virus…

Read More
Rexahn Announces $7.5 Million Registered Direct Offering – Rexahn Pharmaceuticals, Inc.

Rexahn Announces $7.5 Million Registered Direct Offering – Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced it has entered into definitive agreements with institutional investors to purchase approximately 5.77 million shares of…

Read More
2018 BioHealth Capital Region Investment Conference Presentation by Rich Bendis

2018 BioHealth Capital Region Investment Conference Presentation by Rich Bendis

  Top 3 by 2023 State of the BioHealth Capital Region’s EcoSystem Rich Bendis President & CEO, BioHealth Innovation Inc.

Read More
Pharma firmly in the mix as healthcare embraces ‘open innovation’ – MM&M – Medical Marketing and Media

Pharma firmly in the mix as healthcare embraces ‘open innovation’ – MM&M – Medical Marketing and Media

Pharma hasn’t traditionally been known as a sector that welcomed innovation from the outside. But now companies are putting “not invented here” bias aside…

Read More
Job Opportunity: VICE PRESIDENT FOR DEVELOPMENT & ALUMNI RELATIONS at Montgomery College

Job Opportunity: VICE PRESIDENT FOR DEVELOPMENT & ALUMNI RELATIONS at Montgomery College

Based in Rockville, MD Management Recruiters – Mid Hudson Valley is an executive search firm focused solely in serving the nonprofit sector.  We have…

Read More
Maryland Cybersecurity Career & Education Fair  – Nov. 9-10, Rockville, MD

Maryland Cybersecurity Career & Education Fair – Nov. 9-10, Rockville, MD

The Cybersecurity Association of Maryland, Inc. (CAMI) and Universities at Shady Grove invite you to attend their November 9 & 10 Maryland Cybersecurity Career…

Read More
MaxCyte commences dosing in its first clinical trial using its CARMA™ (CAR therapeutic) autologous cell-therapy platform

MaxCyte commences dosing in its first clinical trial using its CARMA™ (CAR therapeutic) autologous cell-therapy platform

MaxCyte, the global cell-based medicines and life sciences company, announced today that the first patient has been dosed in its Phase I dose-escalation clinical…

Read More
Qiagen and Women in Bio Recognized at 5th Annual BioBowl

Qiagen and Women in Bio Recognized at 5th Annual BioBowl

More than 300 representatives of companies from throughout the BioHealth Capital Region took over BowlMore Gaithersburg last Thursday for a fun evening of networking.…

Read More
Women Building Bio 2018 – Virginia Bio

Women Building Bio 2018 – Virginia Bio

Have you register for this year’s Women Building Bio event? The third Annual Women Building Bio Conference is taking place October 17 at the…

Read More
Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax

Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company focused on developing, manufacturing, and commercializing specialty…

Read More
Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg

Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg

Pharma major Lupin announced that it has received tentative approval for its Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and…

Read More
FDA again approves record-breaking number of generic drugs

FDA again approves record-breaking number of generic drugs

The Food and Drug Administration approved or tentatively approved a record-setting 971 generic drugs in fiscal year 2018 that ended last month, the agency…

Read More
M-CERSI Cooperative Agreement Grant Renewed by Food and Drug Administration – Center of Excellence in Regulatory Science and Innovation

M-CERSI Cooperative Agreement Grant Renewed by Food and Drug Administration – Center of Excellence in Regulatory Science and Innovation

The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) has been renewed for funding under a cooperative agreement grant from…

Read More